Sample Name
Sample Code
Sample Name
Sample Code
Sample Name
Sample Code
4
BIDU-SW
09888
5
JD HEALTH
06618
| (Q1)Jun 30, 2025 | (FY)Mar 31, 2025 | (Q1)Jun 30, 2024 | (FY)Mar 31, 2024 | (Q4)Mar 31, 2024 | (Q3)Dec 31, 2023 | (Q2)Sep 30, 2023 | (Q1)Jun 30, 2023 | (FY)Mar 31, 2023 | (Q4)Mar 31, 2023 | |
|---|---|---|---|---|---|---|---|---|---|---|
| Total revenue | 4.76%354.14B | 5.15%1.37T | 4.93%338.05B | 3.46%1.3T | 2.79%305.48B | 0.56%345.84B | 4.31%329.95B | 6.55%322.18B | 9.37%1.26T | 16.20%297.18B |
| Cost of revenue | 3.25%288.36B | 4.58%1.15T | 4.34%279.27B | 1.57%1.1T | 1.80%265.53B | -1.94%290.02B | 2.18%276.59B | 4.76%267.67B | 13.62%1.08T | 20.57%260.83B |
| Gross profit | 11.92%65.78B | 8.23%220.38B | 7.84%58.78B | 15.02%203.63B | 9.89%39.95B | 15.85%55.82B | 16.93%53.36B | 16.31%54.51B | -11.00%177.03B | -7.80%36.35B |
| Operating expense | 5.57%47.52B | 7.19%184.45B | 8.32%45.02B | 3.61%172.07B | 4.75%45.39B | 1.43%42.71B | 3.02%42.42B | 5.29%41.56B | 6.09%166.08B | 5.23%43.33B |
| Selling and administrative expenses | 5.57%47.52B | 7.19%184.45B | 8.32%45.02B | 3.61%172.07B | 4.75%45.39B | 1.43%42.71B | 3.02%42.42B | 5.29%41.56B | 6.09%166.08B | 5.23%43.33B |
| -General and administrative expense | 5.57%47.52B | 7.19%184.45B | 8.32%45.02B | 3.61%172.07B | 4.75%45.39B | 1.43%42.71B | 3.02%42.42B | 5.29%41.56B | 6.09%166.08B | 5.23%43.33B |
| Operating profit | 32.66%18.26B | 13.87%35.93B | 6.28%13.77B | 188.14%31.56B | 22.04%-5.44B | 115.86%13.1B | 145.14%10.94B | 75.10%12.95B | -74.15%10.95B | -298.57%-6.98B |
| Net non-operating interest income (expenses) | -98.62%12M | 300.42%961M | -21.43%869M | -84.31%240M | -147.67%-399M | -91.34%55M | -204.40%-522M | 350.23%1.11B | 188.18%1.53B | 253.02%837M |
| Non-operating interest income | -21.51%1.19B | 14.45%3.68B | -7.30%1.51B | -4.20%3.22B | -70.31%399M | -11.13%1.07B | -6.13%858M | 270.45%1.63B | 52.73%3.36B | 167.20%1.34B |
| Non-operating interest expense | 82.87%1.17B | -8.59%2.72B | 22.52%642M | 62.79%2.98B | 57.40%798M | 78.38%1.02B | 233.33%1.38B | -40.59%524M | -53.49%1.83B | -51.71%507M |
| Net investment income | ||||||||||
| Gain(Loss) on financial instruments designated as cash flow hedges | ||||||||||
| Gain(Loss) on derecognition of available-for-sale financial assets | ||||||||||
| Income from associates and other participating interests | -57.67%-257M | -683.46%-741M | -446.81%-163M | -95.42%127M | 102.21%9M | -146.36%-248M | -68.10%319M | -97.14%47M | -69.27%2.77B | -114.25%-408M |
| Special income (charges) | ||||||||||
| Other non-operating income (expenses) | -92.46%402M | -87.97%1.04B | 13.97%5.33B | 25.60%8.68B | 82.54%2.75B | 77.05%-834M | -28.67%2.08B | -23.52%4.68B | 227.66%6.91B | -27.80%1.51B |
| Income before tax | -7.00%18.42B | -8.38%37.2B | 5.43%19.81B | 83.19%40.6B | 38.90%-3.08B | 234.89%12.08B | 44.37%12.82B | 27.62%18.79B | -57.18%22.16B | -290.27%-5.04B |
| Income tax | -1.15%5.86B | -16.51%9.4B | 2.92%5.93B | 135.91%11.25B | -46.02%-1.45B | 1,037.13%2.88B | 79.86%4.06B | 51.22%5.76B | -63.18%4.77B | -604.06%-993M |
| Net income | -9.51%12.56B | -5.59%27.8B | 11.12%13.87B | 84.33%29.45B | 53.30%-1.63B | 172.26%9.2B | 65.63%9.4B | 19.82%12.49B | -66.47%15.98B | -132.17%-3.5B |
| Net income continuous operations | -9.51%12.56B | -5.26%27.8B | 6.54%13.87B | 68.73%29.35B | 59.71%-1.63B | 135.09%9.2B | 32.26%8.76B | 19.37%13.02B | -55.18%17.39B | -265.08%-4.05B |
| Net income discontinuous operations | ---- | --0 | --0 | 107.20%102M | -100.18%-1M | 99.63%-2M | 167.69%641M | -9.84%-536M | -116.01%-1.42B | -93.42%554M |
| Noncontrolling interests | 37.77%1.14B | -11.09%1.22B | 12.08%826M | 307.26%1.37B | 79.13%-191M | 6.09%-339M | 209.31%1.16B | 208.37%737M | -64.43%-661M | -111.32%-915M |
| Net income attributable to the company | -12.50%11.42B | -5.32%26.59B | 11.06%13.05B | 68.77%28.08B | 44.15%-1.44B | 155.04%9.54B | 55.44%8.24B | 15.39%11.75B | -65.37%16.64B | -122.85%-2.58B |
| Preferred stock dividends | ||||||||||
| Other under preferred stock dividend | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 |
| Net income attributable to common stockholders | -12.50%11.42B | -5.32%26.59B | 11.06%13.05B | 68.77%28.08B | 44.15%-1.44B | 155.04%9.54B | 55.44%8.24B | 15.39%11.75B | -65.37%16.64B | -122.85%-2.58B |
| Gross dividend payment | ||||||||||
| Basic earnings per share | -9.20%115.4 | -3.89%263.05 | 10.90%127.09 | 68.49%273.7 | 44.18%-14.1 | 154.53%92.93 | 55.19%80.28 | 15.19%114.6 | -65.43%162.44 | -122.87%-25.26 |
| Diluted earnings per share | -9.20%115.4 | -3.89%263.05 | 10.90%127.09 | 68.51%273.7 | 44.18%-14.1 | 154.53%92.93 | 55.22%80.28 | 15.21%114.6 | -65.43%162.42 | -122.87%-25.26 |
| Dividend per share | 0 | 13.45%135 | 0 | 8.18%119 | 8.18%119 | 0 | 0 | 0 | 7.84%110 | 7.84%110 |
| Currency Unit | JPY | JPY | JPY | JPY | JPY | JPY | JPY | JPY | JPY | JPY |
| Accounting Standards | NonUS-GAAP | NonUS-GAAP | NonUS-GAAP | NonUS-GAAP | NonUS-GAAP | NonUS-GAAP | NonUS-GAAP | NonUS-GAAP | NonUS-GAAP | NonUS-GAAP |